Literature DB >> 4137779

Letter: Heparin thrombin clotting-time and platelet factor 4.

J R O'Brien, M Etherington, S Jamieson, P Lawford.   

Abstract

Mesh:

Substances:

Year:  1974        PMID: 4137779     DOI: 10.1016/s0140-6736(74)91982-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Letter: Adjustment to low-dose heparin to prevent thrombosis.

Authors:  J R O'Brien
Journal:  Br Med J       Date:  1975-09-20

2.  Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Authors:  M W Kenny; A J George; J Stuart
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

3.  The effect of sulphinpyrazone and alpha-tocopherol on platelet activation and function in haemodialysed patients.

Authors:  A Dmoszyńska-Giannopoulou; L Janicka; B Sokołowska; A Ksiazek; G Orłowska; K Janicki
Journal:  Int Urol Nephrol       Date:  1990       Impact factor: 2.370

4.  Influence of antiplatelet drugs on occlusion of arteriovenous fistula in uraemic patients.

Authors:  K Janicki; A Dmoszyńska; L Janicka; S Stettner; J Jesipowicz
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

5.  Heparin neutralizing activity test in the diagnosis of acute myocardial infarction.

Authors:  J R O'Brien; M Etherington; S Jamieson; P Lawford; J Sussex; S V Lincoln
Journal:  J Clin Pathol       Date:  1975-12       Impact factor: 3.411

6.  Determination of plasma malondialdehyde-like material and its clinical application in stroke patients.

Authors:  M T Santos; J Valles; J Aznar; J Vilches
Journal:  J Clin Pathol       Date:  1980-10       Impact factor: 3.411

7.  Raised plasma concentrations of platelet factor 4 (PF4) in Crohn's disease.

Authors:  M Simi; S Leardi; M T Tebano; M Castelli; F M Costantini; V Speranza
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.